Interestingly, evidence suggests that the atypical pathways, instead of the IKK2-dependent canonical pathway, are the major contributors to the cytoprotective effects of NF-κB activation on oligodendrocytes in MS and EAE [16,25,140]. This evidence concerns the gene IKBKB and myeloid sarcoma.